Trademark Search in Canada

MIDASOLVE

View On IC.GC.CA

REGISTERED

on 9 Oct 2024

Last Applicant/ Owned by

MIDATECH LIMITED

65 Innovation Drive Milton Park AbingdonOxfordshire, OX14 4RQ

Serial Number

1965262 filed on 28^th May 2019

Registration Number

TMA1262131 registered on 9^th Oct 2024

Registration expiry Date

9^th Oct 2034

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

M5H4E3

MIDASOLVE

Trademark usage description

nano-particles ingredients for use in the manufacture of pharmaceuticals, medicines and cosmetics; nano-particles for use as carriers for pharmaceutic Read More

Classification Information

Class [001]
Nano-particles ingredients for use in the manufacture of pharmaceuticals, medicines and cosmetics; nano-particles for use as carriers for pharmaceuticals, medicines and cosmetics; macrocylic compounds, compositions and derivates used as solubilising and stabilising agents for use in manufacturing pharmaceuticals, medicines and cosmetics

Classification kind code

Class [005]
Pharmaceuticals and medicines containing nano-particles for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, and central nervous system related diseases and disorders, viral diseases and disorders, namely common cold, influenza, rabies, measles, diarrhea, hepatitis, yellow fever, polio, smallpox, AIDS, oncoviruses, and spongiform encephalopathies, metabolic diseases and disorders, namely diabetes, hypoglycemia, anemia, bulimia nervosa, anorexia, obesity, gout, osteoarthritis, and muscular dystrophy, endocrine diseases and disorders, namely growth and thyroid disorders, diabetes, osteoporosis, Addison's disease, Cushing's syndrome, Grave's disease, hyperglycemia, hypoglycemia, low testosterone, menopause, and obesity, genitourinary diseases and disorders, namely urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases, neurological diseases and disorders, namely Alzheimers, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, psychiatric diseases and disorders, namely mood disorders, anxiety, cognitive disorders, schizophrenia, cognitive and bipolar disorders, and immune system diseases and disorders, namely autoimmune diseases, and immunologic deficiency syndromes; human vaccines incorporating nano-particles; veterinary vaccines incorporating nano-particles; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals and medicines to treat viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders

Classification kind code

Class [040]
Custom manufacture of nano-particles; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices; custom manufacture of drug delivery agents for facilitating delivery of pharmaceuticals and medicines; custom manufacture of macrocylic compounds, compositions and derivates used as solubilising and stabilising agents for use in manufacturing pharmaceuticals, medicines and cosmetics

Classification kind code

Class [042]
Scientific research services in the field of nano-particle technology; pharmaceutical and drug research, development and discovery services; drug delivery agent research, development and discovery services; testing, efficiency and advisory services in the field of nano-particles, macro-cyclic compounds, pharmaceuticals and nano-medicine; nano-particle laboratory services

Classification kind code

Mark Details

Serial Number

1965262

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 30^th Sept 2024	Registration Pending
Submitted for opposition 42 on 10^th Jul 2024	Advertised
Submitted for opposition 27 on 13^th Jun 2024	Approval Notice Sent
Submitted for opposition 26 on 13^th Jun 2024	Approved
Submitted for opposition 22 on 24^th Jan 2024	Search Recorded
Submitted for opposition 20 on 24^th Jan 2024	Examiner's First Report
Submitted for opposition 287 on 31^st May 2022	Pre-Assessment Letter Sent
Submitted for opposition 31 on 30^th May 2019	Formalized
Submitted for opposition 30 on 28^th May 2019	Filed
Submitted for opposition 1 on 28^th May 2019	Created